)
Edge14 Aug 2026
Deutsche Qualität: The Story of Birkenstock
From an 18th-century German shoemaker to a global footwear brand, how Birkenstock turned an orthopedic insole into the world's most popular sandal.
Bliss GVS Pharma
Bliss GVS Pharma (506197) investor relations material
Bliss GVS Pharma Q1 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 26/27 earnings summary12 Aug, 2026
Executive summary
Board approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, following a review by the Audit Committee and statutory auditors.
Financials prepared in accordance with Ind AS and reviewed with unmodified conclusion by auditors.
Board also approved a postal ballot notice for the appointment of a new Non-Executive Non-Independent Director.
Financial highlights
Consolidated revenue from operations for the quarter ended June 30, 2026, was ₹28,557.56 lakh, up from ₹25,699.32 lakh in the previous quarter and ₹20,746.92 lakh year-over-year.
Consolidated net profit for the quarter was ₹4,303.79 lakh, compared to ₹4,492.33 lakh in the previous quarter and ₹3,557.51 lakh year-over-year.
Total comprehensive income for the quarter was ₹4,889.00 lakh, compared to ₹4,791.80 lakh in the previous quarter and ₹3,313.42 lakh year-over-year.
Basic and diluted EPS for the quarter were ₹4.08 and ₹4.04, respectively.
Outlook and guidance
No explicit forward-looking guidance provided, but continued focus on pharmaceutical and healthcare segment indicated.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Bliss GVS Pharma
- Revenue and net profit rose sharply year-over-year, with a ₹1 dividend proposed.506197
Q4 25/26 - Q3 FY26 net profit reached ₹2,477.91 lakh; interim dividend of 0.50 paisa per share declared.506197Q3 25/26
- Strong revenue and profit growth, improved cash flow, and key management appointment in H1 FY26.506197Q2 25/26
- Strong Q1 FY26 growth in revenue and profit, with key subsidiary divestment completed.506197Q1 25/26
- Revenue and net profit increased, with new leadership and regulatory fine payment noted.506197Q2 24/25
- Q1 FY25 saw year-over-year growth in revenue and profit, with improved margins and ESOP activity.506197Q1 24/25
- Revenue and net profit rose year-over-year, with key divestment and equity actions approved.506197Q4 24/25
- Quarterly and nine-month profits rose, with ESOP share allotments and subsidiary impairments noted.506197Q3 24/25
Next Bliss GVS Pharma earnings date
Q2 26/275 Nov, 2026
Bliss GVS Pharma
Next Bliss GVS Pharma earnings date
Q2 26/275 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage